Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP and Group President | March 31, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 62,852 |
Reported balance
After 2026-03-31 transaction · row 1
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 25,062 · Balance 62,852 F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. |
| Common StockSEC Table I · non-derivative | Direct | 64,356.0985 |
Reported balance
After 2026-04-01 transaction · row 2
1 source rowRow 2 · 2026-04-01 · Tax withholding · Disposed 1,484 · Balance 64,356.0985 F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $71.82 · Expires 2036-03-31 | Direct | 161,676 |
Reported balance
After 2026-03-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-31 · Grant · Acquired 161,676 · Balance 161,676 F3: Option becomes exercisable in three equal annual installments, commencing 3/31/2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
F3: Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 20:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,484 | $72.49 | $107,575.16 |
DisclosureSEC source: 0000064803-26-000043 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,356.0985 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 161,676 | $71.82 Strike: $71.82 | $11,611,570.32 |
DisclosureSEC source: 0000064803-26-000043 · form4.xml · derivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,676 Underlying: Common Stock · 161,676 shares Expires 2036-03-31 F3 · security: Option becomes exercisable in three equal annual installments, commencing 3/31/2027. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 25,062 | $71.82 | $1,799,952.84 |
DisclosureSEC source: 0000064803-26-000043 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,852 F1 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 247 | $80.13 | $19,792.11 |
DisclosureSEC source: 0000064803-26-000002 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,509.3235 F1 · kind: Surrender of shares in payment of withholding taxes due upon the settlement of deferred vested stock units. Read SEC document |
| August 31, 2025 Filed Sep 2, 2025 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 6,995 | $73.15 | $511,684.25 |
DisclosureSEC source: 0001127602-25-021076 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,631.677 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 112,289 | $67.98 Strike: $67.98 | $7,633,406.22 |
DisclosureSEC source: 0001127602-25-011436 · form4.xml · derivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,289 Underlying: Common Stock · 112,289 shares Expires 2035-04-01 F3 · security: Option becomes exercisable in four equal annual installments, commencing on 4/1/2026. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 26,478 | $67.98 | $1,799,974.44 |
DisclosureSEC source: 0001127602-25-011436 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,166 F2 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2026. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,308 | $67.98 | $88,917.84 |
DisclosureSEC source: 0001127602-25-011436 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,250.677 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 846 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-25-009804 · form4.xml · derivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 846 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Option became exercisable in four equal installments commencing 04/01/2019. Upon exercise the reporting person retained all shares. All other options from this award were previously exercised. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 846 | $62.21 | $52,629.66 |
DisclosureSEC source: 0001127602-25-009804 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,189.677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 22:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantPremium Stock Option · Derivative | 746,268 | $71.82 Strike: $71.82 | $53,596,967.76 |
DisclosureSEC source: 0001127602-24-028487 · form4.xml · derivative · entry 14 Shah Prem S · CIK 0001900910 · EVP and Group President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 746,268 Underlying: Common Stock · 746,268 shares Expires 2031-11-30 F12 · security: Option becomes exercisable in three equal annual installments, commencing 11/30/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 62,695 | $79.56 Strike: $79.56 | $4,988,014.20 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · derivative · entry 4 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,695 Underlying: Common Stock · 62,695 shares Expires 2034-04-01 F4 · kind: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 15,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · nonDerivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,057 F3 · kind: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 5,239 | $79.56 | $416,814.84 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,034.463 F2 · kind: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,653 | $79.56 | $211,072.68 |
DisclosureSEC source: 0001127602-24-012258 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,273.463 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 261 | $76.43 | $19,948.23 |
DisclosureSEC source: 0001127602-24-007467 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,185.463 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 23:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 29,473 | $76.95 | $2,267,947.35 |
DisclosureSEC source: 0001127602-24-005449 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,764.7624 F1 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between 76.93 to 76.99 per share. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 22:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 13,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005070 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Pres-Pharm, Consumer W 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,237.7624 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024. Read SEC document |
| August 31, 2023 Filed Sep 1, 2023 20:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,508 | $65.17 | $228,616.36 |
DisclosureSEC source: 0001127602-23-023583 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,987.7242 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 89,073 | $74.31 Strike: $74.31 | $6,619,014.63 |
DisclosureSEC source: 0001127602-23-012254 · form4.xml · derivative · entry 14 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,073 Underlying: Common Stock · 89,073 shares Expires 2033-04-01 F12 · security: Option becomes exercisable in four equal annual installments, commencing 4/1/2024. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,221 | $74.31 | $239,352.51 |
DisclosureSEC source: 0001127602-23-012254 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,364.3199 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 226 | $85.77 | $19,384.02 |
DisclosureSEC source: 0001127602-23-007960 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,403.3199 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (RSU) | 20,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022028 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,376 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date. Read SEC document |
| May 31, 2022 Filed Jun 6, 2022 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (RSU) | 20,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016899 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,671 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments beginning 5/31/2023. Read SEC document |
| May 31, 2022 Filed Jun 30, 2022 22:07 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (RSU) | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-22-000731 · ownership.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This Form 4/A is being filed to amend a Form 4 filed by Mr. Shah on 06/06/2022, which incorrectly reported an award of Restricted Stock Units ("RSUs") with respect to 12,919 shares of the Issuer's common stock. The Form 4 filing was the result of an administrative error. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 4,103 | $0.00 Strike: $74.30 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 18 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,723 Underlying: Common Stock · 4,103 shares Expires 2031-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Option becomes exercisable in three equal installments commencing 04/01/2022. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,719 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 17 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,596 Underlying: Common Stock · 5,719 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 3,157 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 16 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,469 Underlying: Common Stock · 3,157 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 845 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 15 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 845 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,130 | $105.00 | $328,650.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 9 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,453.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 4,103 | $105.00 | $430,815.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 8 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 4,103 | $74.30 | $304,852.90 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 7 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,686.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,719 | $105.00 | $600,495.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 6 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,719 | $58.34 | $333,646.46 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 5 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,302.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 3,157 | $105.00 | $331,485.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 4 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 3,157 | $54.19 | $171,077.83 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,740.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 845 | $105.00 | $88,725.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 845 | $62.21 | $52,567.45 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,428.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 41,580 | $101.09 Strike: $101.09 | $4,203,322.20 |
DisclosureSEC source: 0001127602-22-011635 · form4.xml · derivative · entry 8 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,580 Underlying: Common Stock · 41,580 shares Expires 2032-04-01 F6 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,731 | $101.09 | $377,166.79 |
DisclosureSEC source: 0001127602-22-011635 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:26 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 18,747 | $101.09 | $1,895,134.23 |
DisclosureSEC source: 0001127602-22-011635 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,324.24 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,346 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-010749 · form4.xml · derivative · entry 12 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,346 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: Option becomes exercisable in four equal installments commencing 04/01/2016. F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,346 | $104.70 | $559,726.20 |
DisclosureSEC source: 0001127602-22-010749 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071.24 Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,346 | $102.26 | $546,681.96 |
DisclosureSEC source: 0001127602-22-010749 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,417.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 2,935 | $0.00 Strike: $104.82 | $0.00 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · derivative · entry 13 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935 Underlying: Common Stock · 2,935 shares Expires 2023-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Option becomes exercisable in four equal installments commencing 04/01/2017. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,935 | $106.65 | $313,017.75 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · nonDerivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071.24 Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 2,935 | $104.82 | $307,646.70 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,006.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,689 | $106.65 | $180,131.85 |
DisclosureSEC source: 0001127602-22-009964 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071.24 Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 23:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 141 | $103.65 | $14,614.65 |
DisclosureSEC source: 0001127602-22-007429 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,760.24 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 23:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 226 | $104.30 | $23,571.80 |
DisclosureSEC source: 0001127602-22-007429 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,394.24 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.